US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Antisense & RNAi Technology Market Research Reports & Industry Analysis

Find comprehensive market research and company reports on the AntiSense & RNAi Technology Industry. More specifically, find reports on the Cancer Therapies, Bioinformatics and Bioprocessing markets. Reports include data on market segmentation, size and growth in US, UK, Europe, Asia and global markets.
RSS Feeds

Antisense & RNAi Technology Industry Research & Market Reports

< prev 1    3  
miRNA Research and Diagnostics Markets
9/4/2014 | published by: Kalorama Information
... the post-transcriptional level. These small bits of RNA, members of a class of non-translated molecules that do not produce protein, shut off gene transcription by base pairing with the target molecules.  They are now recognized as ...  |  read more...
USD 2,995
RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019
9/26/2014 | published by: MarketsandMarkets
... expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past ...  |  read more...
USD 4,650
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... drugs known to affect more than 157 specific intracellular signaling pathways for the treatment of more than 25 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding ...  |  read more...
USD 2,246
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... molecules or protein-based therapies. There are today 58 companies plus partners developing 107 RNA (miRNA, RNAi & siRNA) drugs in 144 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the ...  |  read more...
USD 4,496
RNAi Drug Delivery: Technologies and Global Markets
6/1/2014 | published by: BCC Research
... $38.8 billion in 2018, with a compound annual growth rate(CAGR) of 27.2% from 2013 to 2018. This report provides: An overview of the global market for RNA interference (RNAi) in major therapeutic and drug delivery ...  |  read more...
USD 6,650
RNAi for Therapeutic Applications: Technology and Market 2014-2024
2/12/2014 | published by: Visiongain
... new sales predictions and explore developments. You unlock that emerging medical industry. And you assess its results, trends, technologies, potentials, and opportunities. Visiongain's new report forecasts those revenues to 2024 at overall world market, product, ...  |  read more...
USD 3,004
Global RNAi Drug Delivery Market 2014-2018
1/17/2014 | published by: TechNavio - Infiniti Research Ltd.
... this market growth is the increase in RNA therapeutic development. The Global RNAi Drug Delivery market has also been witnessing some key technological advancements. However, the targeted delivery of RNA molecules is expected to pose ...  |  read more...
USD 2,000
Biotechnology: RNAi
5/1/2014 | published by: RI Technologies
... of World. The RNAi Tools/Products are further segmented into Design/Software (miRNA Target Scan, miRNA Analysis Software, and Design Software), Synthesis (Expression Vectors, Chemical, miRNA Isolation, Dicer/RNAseIII, and In Vitro), Delivery (Vector Based, Transfection Reagents, and ...  |  read more...
USD 4,680
Antisense Therapeutics Limited - Product Pipeline Review - 2014
1/31/2014 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
USD 1,500
2013 Biotechnology Research Review
12/1/2013 | published by: BCC Research
... and $290 million by 2018, with a compound annual growth rate (CAGR) of 5.7% for the period of 2013 to 2018. The next generation sequencing market reached $231.7 million in 2012. The market is expected ...  |  read more...
USD 950
RNAi Technologies and Global Markets
10/1/2013 | published by: BCC Research
... with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) for the period 2013 to 2018. A breakdown of the technologies: RNAi for drug delivery (by nanoparticle delivery, ...  |  read more...
USD 6,650
Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
7/5/2013 | published by: MarketsandMarkets
... market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018. Aptamers existed in parallel with antibodies for two decades, but its market potential was not utilized, even to ...  |  read more...
USD 4,650
2012 Oncology Market Research Review
12/1/2012 | published by: BCC Research
... and markets by therapeutic area. Implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and by the most important ...  |  read more...
USD 950
Conference Documentation: RNA Therapeutics
6/5/2013 | published by: SMI Publishing, Ltd
... the key to the eradication of a number of diseases. SMi’s 2013 RNA Therapeutics conference will look to discuss and share some of the latest findings and research in the field of RNAi technologies and ...  |  read more...
USD 788.78
Epigenetic Therapies and Technologies: World Market Prospects 2013-2023
1/9/2013 | published by: Visiongain
... for those therapies, technologies and diagnostic products. There you find sales data, R&D trends, opportunities and commercial prospects. That analysis lets you assess forecasted sales at overall world market, submarket, product, regional and national level. ...  |  read more...
USD 2,587
The U.S. Market and Developments Associated with Psoriasis
7/1/2001 | published by: Kalorama Information
... the potential for actual curative therapy. This dedicated report from Kalorama Information examines the current and future market for therapeutic agents, including " Natural" approaches in the treatment of psoriasis. Product areas include: Current Products/methods ...  |  read more...
USD 1,496
Market for Genitourinary Pharmaceuticals
10/1/1996 | published by: Kalorama Information
... silence, are driving the development of innovative pharmacological solutions to these age-related problems. Also, will biotechnology produce a treatment for genitourinary cancers? This Kalorama Information report explores these issues and more. The major companies competing ...  |  read more...
USD 1,625
Market For Gene Therapy and Antisense Drugs
8/1/1995 | published by: Kalorama Information
... $60 billion in 2005. This report from Kalorama Information examines the advantages and disadvantages of the various types of gene therapy and assesses which technologies and companies are likely to lead the market. Examines the ...  |  read more...
USD 1,625
Advances in Cancer Therapy
2/1/2001 | published by: Kalorama Information
... many cancer patients are managed as if they were chronically ill. These thoughts are being shaped and driven by a variety of forces: A new paradigm that would make use of the patient's natural immune ...  |  read more...
USD 350
Special Package: Current Developments in Immunotherapy Markets and Technology and Advances in Cancer Therapy
4/1/2001 | published by: Kalorama Information
... major disease areas such as hypersensitivity/allergy and cancer. The application in organ transplantation dealing with prevention of allograph rejection and transplantation sickness has long been known. This report from MarketResearch.com examines this market and provides ...  |  read more...
USD 5,950
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
12/1/2010 | published by: Kalorama Information
... other novel compounds targeting drugs to specific disease sites including gene therapy. Treatments for chronic conditions and growth in patient-administered drugs are factors leading to greater focus on ease-of-use and convenience. Advanced Drug Delivery Markets ...  |  read more...
USD 2,500
Market for Antiviral Therapeutics and Vaccines
1/1/1996 | published by: Kalorama Information
... rubella vaccines; polio vaccines; respiratory syncytial virus therapeutics; and products used to treat rare diseases. Offers historical information for the past 5 years and forecasts for the next 5 years. Profiles include established and emerging ...  |  read more...
USD 1,625
Opportunities in Stem Cell Technology
2/1/2002 | published by: Kalorama Information
... identify those technologies and opportunities in the United States with the greatest future opportunities, the opportunities to develop enabling technologies in the field, and the organizations and laboratories performing current research. In addition, a section ...  |  read more...
USD 2,625
Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications
1/1/2005 | published by: Kalorama Information
... is an idea whose time has come. There are six types of nucleic acid-based therapeutics that have been proposed. Some have made it to market, others are still in development, and some have been put ...  |  read more...
USD 3,500
Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
6/1/2011 | published by: VPGMarketResearch.com
... seven major markets Five- and ten-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Profiles of market players and start-up firms developing innovative technologies and products Specific product ...  |  read more...
USD 28,500
< prev 1    3